阿爾法發射核素市場：依放射性核種類型、應用分類 - 2024-2030 年全球預測

預計2023年α發射核種市場規模為8.8695億美元，2024年將達10.6244億美元，2030年將達32.1195億美元，複合年成長率為20.18%。

全球α發射核素市場

FPNV定位矩陣

FPNV定位矩陣對於評估α發射核種市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對 α 發射核素市場中供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴見解，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略，從而在市場上獲得競爭優勢。

該報告對以下幾個方面提供了寶貴的見解：

1-市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2-市場開拓：我們深入研究利潤豐厚的新興市場，並分析它們在成熟細分市場中的滲透率。

3- 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4-競爭力評估與資訊：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。

5- 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題：

1-α發射核種市場的市場規模和預測是多少？

2-在阿爾法發射核素市場的預測期內，需要考慮投資哪些產品、細分市場、應用和領域？

3-α發射核種市場的技術趨勢和法律規範是什麼？

4-α發射核種市場主要供應商的市場佔有率是多少？

5-進入α發射核種市場的適當型態和策略手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

• 市場動態
  • 促進因素
    • 心臟病和癌症患者數量增加
    • 提高人們對目標阿爾法發送器潛在好處的認知
    • α發射核素在工業的新興用途
  • 抑制因素
    • α發射核素的生產成本較高。
  • 機會
    • 癌症治療新臨床試驗活動的出現
    • 持續進行研發活動，探索α發射核素的新應用領域
  • 任務
    • α發射核素的複雜處理與安全性問題
• 市場區隔分析
• 市場趨勢分析
• 高通膨的累積效應
• 波特五力分析
• 價值鍊和關鍵路徑分析
• 法律規範

第6章以放射性核種類型分類的α發射核素市場

• 錒225
• 鋂-241
• 砈-211
• 鈽239
• 鐳226
• 鈾238

第7章 阿爾法發射核素市場：依應用分類

• 工業的
• 藥品
  • 骨轉移
  • 內分泌腫瘤
  • 卵巢癌
  • 胰臟癌
  • 攝護腺癌

第8章美洲阿爾法核素市場

• 阿根廷
• 巴西
• 加拿大
• 墨西哥
• 美國

第9章亞太地區α排放核素市場

• 澳洲
• 中國
• 印度
• 印尼
• 日本
• 馬來西亞
• 菲律賓
• 新加坡
• 韓國
• 台灣
• 泰國
• 越南

第10章 歐洲、中東和非洲α排放核素市場

• 丹麥
• 埃及
• 芬蘭
• 法國
• 德國
• 以色列
• 義大利
• 荷蘭
• 奈及利亞
• 挪威
• 波蘭
• 卡達
• 俄羅斯
• 沙烏地阿拉伯
• 南非
• 西班牙
• 瑞典
• 瑞士
• 土耳其
• 阿拉伯聯合大公國
• 英國

第11章競爭形勢

• FPNV定位矩陣
• 市場佔有率分析：主要企業
• 主要企業競爭情境分析

第12章競爭產品組合

• 主要公司簡介
  • Actinium Pharmaceuticals, Inc.
  • Alpha Tau Medical Ltd.
  • Bayer AG
  • Bracco SpA
  • Cardinal Health, Inc.
  • Eckert & Ziegler
  • Fusion Pharmaceuticals Inc.
  • Ionetix Corporation
  • Niowave Inc.
  • Orano Group
  • RadioMedix, Inc.
  • Siemens Healthineers
  • Telix Pharmaceuticals Limited
• 主要產品系列

第13章附錄

• 討論指南
• 關於許可證和定價

[185 Pages Report] The Alpha Emitters Market size was estimated at USD 886.95 million in 2023 and expected to reach USD 1,062.44 million in 2024, at a CAGR 20.18% to reach USD 3,211.95 million by 2030.

Global Alpha Emitters Market

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Alpha Emitters Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Alpha Emitters Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Alpha Emitters Market, highlighting leading vendors and their innovative profiles. These include Actinium Pharmaceuticals, Inc., Alpha Tau Medical Ltd., Bayer AG, Bracco S.p.A., Cardinal Health, Inc., Eckert & Ziegler, Fusion Pharmaceuticals Inc., Ionetix Corporation, Niowave Inc., Orano Group, RadioMedix, Inc., Siemens Healthineers, and Telix Pharmaceuticals Limited.

Market Segmentation & Coverage

This research report categorizes the Alpha Emitters Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Radionuclide Type
  • Actinium-225
  • Americium-241
  • Astatine-211
  • Plutonium-239
  • Radium-226
  • Uranium-238
• Application
  • Industrial
  • Medical
    • Bone Metastasis
    • Endocrine Tumors
    • Ovarian Cancer
    • Pancreatic Cancer
    • Prostate Cancer
• Region
  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Alpha Emitters Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Alpha Emitters Market?

3. What are the technology trends and regulatory frameworks in the Alpha Emitters Market?

4. What is the market share of the leading vendors in the Alpha Emitters Market?

5. Which modes and strategic moves are suitable for entering the Alpha Emitters Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Alpha Emitters Market, by Region

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing number of patients with cardiac and cancer ailments
    • 5.1.1.2. Increased awareness of potential benefits of targeted alpha emitter
    • 5.1.1.3. Emerging use of alpha emitters in industrial sectors
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of production of alpha emitters
  • 5.1.3. Opportunities
    • 5.1.3.1. Emerging new clinical trial activities for cancer treatment
    • 5.1.3.2. Ongoing R&D activities for exploring new application areas of alpha emitters
  • 5.1.4. Challenges
    • 5.1.4.1. Complex handling and safety hazards of alpha emitters
• 5.2. Market Segmentation Analysis
• 5.3. Market Trend Analysis
• 5.4. Cumulative Impact of High Inflation
• 5.5. Porter's Five Forces Analysis
  • 5.5.1. Threat of New Entrants
  • 5.5.2. Threat of Substitutes
  • 5.5.3. Bargaining Power of Customers
  • 5.5.4. Bargaining Power of Suppliers
  • 5.5.5. Industry Rivalry
• 5.6. Value Chain & Critical Path Analysis
• 5.7. Regulatory Framework

6. Alpha Emitters Market, by Radionuclide Type

• 6.1. Introduction
• 6.2. Actinium-225
• 6.3. Americium-241
• 6.4. Astatine-211
• 6.5. Plutonium-239
• 6.6. Radium-226
• 6.7. Uranium-238

7. Alpha Emitters Market, by Application

• 7.1. Introduction
• 7.2. Industrial
• 7.3. Medical
  • 7.4.1. Bone Metastasis
  • 7.4.2. Endocrine Tumors
  • 7.4.3. Ovarian Cancer
  • 7.4.4. Pancreatic Cancer
  • 7.4.5. Prostate Cancer

8. Americas Alpha Emitters Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Alpha Emitters Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Alpha Emitters Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. FPNV Positioning Matrix
• 11.2. Market Share Analysis, By Key Player
• 11.3. Competitive Scenario Analysis, By Key Player

12. Competitive Portfolio

• 12.1. Key Company Profiles
  • 12.1.1. Actinium Pharmaceuticals, Inc.
  • 12.1.2. Alpha Tau Medical Ltd.
  • 12.1.3. Bayer AG
  • 12.1.4. Bracco S.p.A.
  • 12.1.5. Cardinal Health, Inc.
  • 12.1.6. Eckert & Ziegler
  • 12.1.7. Fusion Pharmaceuticals Inc.
  • 12.1.8. Ionetix Corporation
  • 12.1.9. Niowave Inc.
  • 12.1.10. Orano Group
  • 12.1.11. RadioMedix, Inc.
  • 12.1.12. Siemens Healthineers
  • 12.1.13. Telix Pharmaceuticals Limited
• 12.2. Key Product Portfolio

13. Appendix

• 13.1. Discussion Guide
• 13.2. License & Pricing

LIST OF FIGURES

• FIGURE 1. ALPHA EMITTERS MARKET RESEARCH PROCESS
• FIGURE 2. ALPHA EMITTERS MARKET SIZE, 2023 VS 2030
• FIGURE 3. ALPHA EMITTERS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. ALPHA EMITTERS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
• FIGURE 5. ALPHA EMITTERS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. ALPHA EMITTERS MARKET DYNAMICS
• FIGURE 7. ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2023 VS 2030 (%)
• FIGURE 8. ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 9. ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 10. ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 11. AMERICAS ALPHA EMITTERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 12. AMERICAS ALPHA EMITTERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 13. UNITED STATES ALPHA EMITTERS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 14. UNITED STATES ALPHA EMITTERS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 15. ASIA-PACIFIC ALPHA EMITTERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 16. ASIA-PACIFIC ALPHA EMITTERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ALPHA EMITTERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ALPHA EMITTERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 19. ALPHA EMITTERS MARKET, FPNV POSITIONING MATRIX, 2023
• FIGURE 20. ALPHA EMITTERS MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

• TABLE 1. ALPHA EMITTERS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. ALPHA EMITTERS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL ALPHA EMITTERS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
• TABLE 6. ALPHA EMITTERS MARKET SIZE, BY ACTINIUM-225, BY REGION, 2018-2030 (USD MILLION)
• TABLE 7. ALPHA EMITTERS MARKET SIZE, BY AMERICIUM-241, BY REGION, 2018-2030 (USD MILLION)
• TABLE 8. ALPHA EMITTERS MARKET SIZE, BY ASTATINE-211, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. ALPHA EMITTERS MARKET SIZE, BY PLUTONIUM-239, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. ALPHA EMITTERS MARKET SIZE, BY RADIUM-226, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. ALPHA EMITTERS MARKET SIZE, BY URANIUM-238, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 13. ALPHA EMITTERS MARKET SIZE, BY INDUSTRIAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. ALPHA EMITTERS MARKET SIZE, BY MEDICAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 16. ALPHA EMITTERS MARKET SIZE, BY BONE METASTASIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. ALPHA EMITTERS MARKET SIZE, BY ENDOCRINE TUMORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. ALPHA EMITTERS MARKET SIZE, BY OVARIAN CANCER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. ALPHA EMITTERS MARKET SIZE, BY PANCREATIC CANCER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. ALPHA EMITTERS MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS ALPHA EMITTERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 25. ARGENTINA ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
• TABLE 26. ARGENTINA ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 27. ARGENTINA ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 28. BRAZIL ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
• TABLE 29. BRAZIL ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 30. BRAZIL ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 31. CANADA ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
• TABLE 32. CANADA ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 33. CANADA ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 34. MEXICO ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
• TABLE 35. MEXICO ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 36. MEXICO ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 37. UNITED STATES ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
• TABLE 38. UNITED STATES ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 39. UNITED STATES ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 40. UNITED STATES ALPHA EMITTERS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 41. ASIA-PACIFIC ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
• TABLE 42. ASIA-PACIFIC ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 43. ASIA-PACIFIC ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 44. ASIA-PACIFIC ALPHA EMITTERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 45. AUSTRALIA ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
• TABLE 46. AUSTRALIA ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 47. AUSTRALIA ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 48. CHINA ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
• TABLE 49. CHINA ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 50. CHINA ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 51. INDIA ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
• TABLE 52. INDIA ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 53. INDIA ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 54. INDONESIA ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
• TABLE 55. INDONESIA ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 56. INDONESIA ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 57. JAPAN ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
• TABLE 58. JAPAN ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 59. JAPAN ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 60. MALAYSIA ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
• TABLE 61. MALAYSIA ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 62. MALAYSIA ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 63. PHILIPPINES ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
• TABLE 64. PHILIPPINES ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 65. PHILIPPINES ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 66. SINGAPORE ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
• TABLE 67. SINGAPORE ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 68. SINGAPORE ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 69. SOUTH KOREA ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
• TABLE 70. SOUTH KOREA ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 71. SOUTH KOREA ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 72. TAIWAN ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
• TABLE 73. TAIWAN ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 74. TAIWAN ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 75. THAILAND ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
• TABLE 76. THAILAND ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 77. THAILAND ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 78. VIETNAM ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
• TABLE 79. VIETNAM ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 80. VIETNAM ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 81. EUROPE, MIDDLE EAST & AFRICA ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
• TABLE 82. EUROPE, MIDDLE EAST & AFRICA ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 83. EUROPE, MIDDLE EAST & AFRICA ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 84. EUROPE, MIDDLE EAST & AFRICA ALPHA EMITTERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 85. DENMARK ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
• TABLE 86. DENMARK ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 87. DENMARK ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 88. EGYPT ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
• TABLE 89. EGYPT ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 90. EGYPT ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 91. FINLAND ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
• TABLE 92. FINLAND ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 93. FINLAND ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 94. FRANCE ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
• TABLE 95. FRANCE ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 96. FRANCE ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 97. GERMANY ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
• TABLE 98. GERMANY ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 99. GERMANY ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 100. ISRAEL ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
• TABLE 101. ISRAEL ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 102. ISRAEL ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 103. ITALY ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
• TABLE 104. ITALY ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 105. ITALY ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 106. NETHERLANDS ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
• TABLE 107. NETHERLANDS ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 108. NETHERLANDS ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 109. NIGERIA ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
• TABLE 110. NIGERIA ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 111. NIGERIA ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 112. NORWAY ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
• TABLE 113. NORWAY ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 114. NORWAY ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 115. POLAND ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
• TABLE 116. POLAND ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 117. POLAND ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 118. QATAR ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
• TABLE 119. QATAR ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 120. QATAR ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 121. RUSSIA ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
• TABLE 122. RUSSIA ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 123. RUSSIA ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 124. SAUDI ARABIA ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
• TABLE 125. SAUDI ARABIA ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 126. SAUDI ARABIA ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 127. SOUTH AFRICA ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
• TABLE 128. SOUTH AFRICA ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 129. SOUTH AFRICA ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 130. SPAIN ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
• TABLE 131. SPAIN ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 132. SPAIN ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 133. SWEDEN ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
• TABLE 134. SWEDEN ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 135. SWEDEN ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 136. SWITZERLAND ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
• TABLE 137. SWITZERLAND ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 138. SWITZERLAND ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 139. TURKEY ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
• TABLE 140. TURKEY ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 141. TURKEY ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 142. UNITED ARAB EMIRATES ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
• TABLE 143. UNITED ARAB EMIRATES ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 144. UNITED ARAB EMIRATES ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 145. UNITED KINGDOM ALPHA EMITTERS MARKET SIZE, BY RADIONUCLIDE TYPE, 2018-2030 (USD MILLION)
• TABLE 146. UNITED KINGDOM ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 147. UNITED KINGDOM ALPHA EMITTERS MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
• TABLE 148. ALPHA EMITTERS MARKET, FPNV POSITIONING MATRIX, 2023
• TABLE 149. ALPHA EMITTERS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 150. ALPHA EMITTERS MARKET LICENSE & PRICING